Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized study on neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma
2007-000557-61Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of gemcitabine in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Rate of potentially curative treatment. Started Apr 2007; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2007-000557-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000557-61.